MAPS Invites RWE Expert to Discuss MSL Mind Reading
VISFO Chief Medical Officer David Williams recently spoke with the Medical Affairs Professional Society (MAPS) about industry trends when it [...]
Stanford’s Atropos Health Offshoot Seeks to Inform Patient Care Using RWD
Stanford University offshoot Atropos Health seeks to inform healthcare decision-making using real world data (RWD). Launched in September, the consultancy [...]
Register Now for October ISPOR Webinar on Venture Capital Investment in Healthcare
The International Society for Pharmacoeconomics and Outcomes (ISPOR) is hosting a webinar on October 26th at 11:00 AM EDT on venture [...]
Cochrane Deputy Editor in Chief Discusses New Partnership with NICE
Cochrane and the National Institute for Health and Care Excellence (NICE) have announced a partnership to share in-progress articles for [...]
PRMA Consulting Senior Advisor Discusses the Four Pillars of Market Access and New Pharma Trends
Senior Advisor, Asia-Pacific at PRMA Consulting Jeff Weisel shared an update to his previous article detailing the four strategic pillars [...]
New Book on Historic and Future Pharma Trends Now Available
A recently published book authored by Mickey C. Smith, PhD details the multi-faceted issues facing pharma and healthcare. Francis B. [...]
MAPS Webinar on Considerations for External Research
The Medical Affairs Professional Society (MAPS) has released a webinar detailing considerations for external research studies. The webinar highlights privacy [...]
MAPS Releases Whitepaper on Field Medical Metrics and KPIs
The Medical Affairs Professional Society (MAPS) has released a whitepaper detailing how field medical metrics and key performance indicators (KPIs) [...]
ICER Meets With FDA, EMA, and FDA to Discuss RWE Procedures
In a recent meeting, members of the Institute for Clinical and Economic Review (ICER), the Food and Drug Administration (FDA), [...]
ISPOR 2022 Meeting Seeking Abstracts on RWE and HEOR
The International Society for Pharmacoeconomics and Outcomes (ISPOR) is seeking abstracts for its 2022 meeting, held both in-person and virtually next [...]
Part 2 of Aetion’s ICPE Research Spotlight Highlights RWD in COVID-19 Research and Updated RWE Guidance
According to Aetion, key highlights of the August ICPE All Access Meeting hosted by the International Society for Pharmacology (ISPE) [...]
Aetion and NICE Partner to Leverage RWE in Comparative Effectiveness Studies
Aetion and the National Institute for Health and Care Excellence (NICE) have announced a partnership intended to advance comparative effectiveness [...]
Syneos Health Announces Acquisition of RxDataScience
Syneos Health has announced its acquisition of RxDataScience, a healthcare analytics company. The move will broaden Syneos Health’s offerings related [...]
Part 3 of MHE Interview With Prime Therapeutics CEO and President Now Available
Managed Healthcare Executive recently interviewed Prime Therapeutics CEO and President Ken Paulus. Paulus details the benefits of Prime Therapeutics’ recent [...]
Cytel Statistician Discusses the Importance of Traceability in R&D Data Handling
Cytel’s Angelo Tinazzi discusses data traceability in a recent blog post. An expert in statistical programming and clinical data analysis, [...]
New EMWA Article Explores Health Economic Evaluations and CHEERS Guidelines
An article published in the European Medical Writers Association’s Medical Writing journal explores the role of health economic evaluations in [...]
New InformED Podcast on Health Equity, Disparities, and Literacy Now Available
A new episode of the International Society for Medical Publication Professionals’ InformED podcast series is now available. Sponsored by MedThink [...]
Register Now for Upcoming Regulatory RWE Webinar
Flatiron Health will hold a webinar highlighting how real world evidence (RWE) studies can aid in obtaining regulatory approval. Speakers [...]
How Can NMAs and ITCs Add Value to HTAs?
The Evidence Base recently interviewed Dutch researcher Daan Reid. He shared his thoughts on health technology assessments (HTAs) and improving [...]
Interview With RWE Expert on Expectations for FDA Framework
In a recent interview with The Evidence Base, real world evidence (RWE) expert Sreeram Ramagopalan shared his thoughts on the [...]
MAPS Whitepaper on Meaningful Metrics in Medical Affairs
A recent whitepaper highlights the use of various metrics by medical affairs (MA) professionals to assess value. Both qualitative and [...]
HEOR Expert Discusses RWE Career Paths and Emerging Healthcare Technologies
In a recent interview with The Evidence Base, Olivia Wu discussed her day-to-day work, the many career paths available to [...]
Register Now for Upcoming October Webinar on Visualizing RWE
An upcoming webinar on visualizing real world evidence (RWE) will take place at 11:00 AM on Thursday, October 7th. Speakers [...]
ICER Publishes Draft Evidence Report on Asthma Drug; Register Now for October Webinar
The Institute for Clinical and Economic Review (ICER) has published its Draft Evidence Report for severe asthma drug tezepelumab. The [...]
IQVIA Whitepaper on the Natural History of Disease Features Discussions on RWE, Big Data, and COVID-19
A recent IQVIA whitepaper brought together multidisciplinary experts to discuss the natural history of disease. The discussion focused on the [...]